Home
Network
Publications
Training
Documents
News
Contact

Menu

Home
Network
Publications
Training
Documents
News
Contact

Search

Close

Posted on May 7, 2019 by adminclonal

Chrono-pharmacological Targeting of the CCL2-CCR2 Axis Ameliorates Atherosclerosisz

CategoriesOliver SoehnleinTagsde Jong R, Drechsler M, Hidalgo A, Hristov M, Immler R, Lemnitzer P, Nicolaes GAF, Ortega-Gomez A, Poelman H, Scheiermann C, Schumski A, Silvestre-Roig C, Soehnlein O. Cell Metab, Sperandio M, Viola JR, Weber C, Winter C, Winter J, Zeller T

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Please enter an answer in digits:

14 − 5 =

Post navigation

Previous PostPrevious Double-Strand DNA Sensing Aim2 Inflammasome Regulates Atherosclerotic Plaque Vulnerability

Next PostNext Recruitment of classical monocytes can be inhibited by disturbing heteromers of neutrophil HNP1 and platelet CCL5

This research is supported by a grant from the Fondation Leducq All rights reserved. 2019 Clonal Hematopohiesis and Atherosclerosis info@clonal-hematopoiesis-leducq.com

Top